Our results agree with previously published studies indicating that increased STYK1 expression correlates with enhanced tumor growth and invasiveness in NSCLC and with poorer prognosis for NSCLC patients, making STYK1 also a potential prognostic marker [14, 18, 32]. Here, STYK1 is linked to neoplasm.